Scott Edil Pharmacia Limited — Lisinopril Exporter Profile
Indian Pharmaceutical Exporter · #14 for Lisinopril · $380.4K export value · DGFT Verified
Scott Edil Pharmacia Limited is the #14 Indian exporter of Lisinopril with $380.4K in export value and 21 verified shipments. Scott Edil Pharmacia Limited holds a 0.6% market share in Lisinopril exports across 4 countries. The company exports 23 pharmaceutical products worth $25.5M across 10 therapeutic categories.
Scott Edil Pharmacia Limited — Lisinopril Export Profile: Buyers & Destinations
Where Does Scott Edil Pharmacia Limited Export Lisinopril?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $352.3K | 17 | 96.1% |
| DOMINICAN REPUBLIC | $5.6K | 1 | 1.5% |
| VENEZUELA | $5.0K | 2 | 1.4% |
| TURKMENISTAN | $3.7K | 1 | 1.0% |
Scott Edil Pharmacia Limited exports Lisinopril to 4 countries. The largest destination is NIGERIA accounting for 96.1% of Scott Edil Pharmacia Limited's Lisinopril shipments, followed by DOMINICAN REPUBLIC (1.5%) and VENEZUELA (1.4%). These destinations reflect Scott Edil Pharmacia Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Lisinopril from Scott Edil Pharmacia Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | NIGERIA | $213.9K | 12 |
| TO THE DIRECTOR OF | NIGERIA | $51.8K | 3 |
| FIRST J POCCO PHARMACY LIMITED | NIGERIA | $50.0K | 1 |
| TO THE ORDER OF COMMERCIAL | NIGERIA | $36.6K | 1 |
| VITAL NET.AV96(PASEO CABRIALES)EDIT | VENEZUELA | $4.2K | 1 |
| SAG AMAN HK | TURKMENISTAN | $3.7K | 1 |
| VITAL NET.AV 96 (PASEO CABRIALES) | VENEZUELA | $841 | 1 |
Scott Edil Pharmacia Limited supplies Lisinopril to 7 buyers globally. The largest buyer is TO THE ORDER (NIGERIA), followed by TO THE DIRECTOR OF (NIGERIA) and FIRST J POCCO PHARMACY LIMITED (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Lisinopril Export Value and How Much Does Scott Edil Pharmacia Limited Contribute?
India exported $15.9M worth of Lisinopril through 3,514 shipments from 221 suppliers to 94 countries, serving 450 buyers globally. Scott Edil Pharmacia Limited contributes $380.4K to this total, accounting for 0.6% of India's Lisinopril exports. Scott Edil Pharmacia Limited ships Lisinopril to 4 countries through 7 buyers.
What Is the Average Shipment Value for Scott Edil Pharmacia Limited's Lisinopril Exports?
Scott Edil Pharmacia Limited's average Lisinopril shipment value is $18.1K per consignment, based on 21 shipments totaling $380.4K. The largest destination is NIGERIA (96.1% of Scott Edil Pharmacia Limited's Lisinopril exports).
How Does Scott Edil Pharmacia Limited Compare to Other Indian Lisinopril Exporters?
Scott Edil Pharmacia Limited ranks #14 among 221 Indian Lisinopril exporters with a 0.6% market share. The top 3 exporters are LUPIN LIMITED ($4.3M), IPCA LABORATORIES LIMITED ($2.7M), MICRO LABS LIMITED ($1.9M). Scott Edil Pharmacia Limited processed 21 shipments to 4 destination countries.
What Lisinopril Formulations Does Scott Edil Pharmacia Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION LISINOPRIL 10MG TAB,BATCHNO:XT3L049,XT3L050,XT3L051,XT3L052NOS | $101.6K | 6 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION LISINOPRIL 5MG TAB ,(OTHER DETAILS AS PER INV & PKG LIST)THD | $95.8K | 2 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION LISINOPRIL TABLLET USP 10MG(B NO. XT3L063,64,65,66) | $51.8K | 3 |
| LISINOPRIL 10MG TAB 10X2X14 (POCCO) LISI | $50.0K | 1 |
| HARMLESS PHARMACEUTICAL MED FINISHED FORMULATION LISINOPRIL 10MG TAB (MFG & EXPDT: 12/2023 & 11/2026) | $36.6K | 1 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION LISINOPRIL 10MG TAB,BATCHNO:XT3L049THD | $14.7K | 2 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION LISINOPRIL TABLET USP 20MG B.NO: XT5B001 MFG:02/25 EXP:01/28 | $5.6K | 1 |
| PHARMACEUTICALS PRODUCTS-(FG) LISINOPRIL | $4.2K | 1 |
| LISINOPRIL 10MG (2X14) BLISTER TAB LISIN | $3.7K | 1 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION LISINOPRIL 5MG TAB BATCHNO.XT3L040NOS | $1.8K | 2 |
Scott Edil Pharmacia Limited exports 11 distinct Lisinopril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION LISIN with 6 shipments worth $101.6K.
Regulatory Requirements: Exporting Lisinopril to Key Markets
What Scott Edil Pharmacia Limited must comply with to export Lisinopril to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Scott Edil Pharmacia Limited Compare to Nearest Lisinopril Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | WATSON PHARMA PRIVATE LIMITED | $505.3K | 17 | 1 | $29.7K |
| 13 | SR PHARMACEUTICAL INDUSTRIES PRIVATE LIMITED | $419.3K | 10 | 1 | $41.9K |
| 14 | SCOTT EDIL PHARMACIA LIMITED ★ | $380.4K | 21 | 4 | $18.1K |
| 15 | WINTECH PHARMACEUTICALS LIMITED | $303.1K | 10 | 1 | $30.3K |
| 6 | STALLION LABORATORIES PRIVATE LIMITED | $300.0K | 6 | 1 | $50.0K |
Scott Edil Pharmacia Limited ranks #14 among 221 Indian Lisinopril exporters. Average shipment value of $18.1K compared to the market average of $72.1K. The closest competitors by value are WATSON PHARMA PRIVATE LIMITED and SR PHARMACEUTICAL INDUSTRIES PRIVATE LIMITED.
Which Indian Ports Ship Lisinopril Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 597 | 17.0% |
| DELHI AIR CARGO ACC (INDEL4) | 514 | 14.6% |
| SAHAR AIR | 509 | 14.5% |
| DELHI AIR | 282 | 8.0% |
| NHAVA SHEVA SEA (INNSA1) | 238 | 6.8% |
| Bombay Air | 172 | 4.9% |
| HYDERABAD ICD (INSNF6) | 112 | 3.2% |
| Delhi Air | 110 | 3.1% |
What Other Cardiovascular Products Does Scott Edil Pharmacia Limited Export?
Scott Edil Pharmacia Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Scott Edil Pharmacia Limited's Lisinopril Exports
Scott Edil's export operations are influenced by several current geopolitical factors. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses for Indian pharmaceutical exporters. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) estimates potential losses ranging between ₹2,500 crore and ₹5,000 crore due to these disruptions. (outlookbusiness.com) Such challenges necessitate strategic adjustments in logistics and supply chain management for companies like Scott Edil.
In the United States, recent tariff implementations have introduced uncertainties for Indian pharmaceutical exporters. While specific impacts on Scott Edil are not detailed, the broader industry faces challenges due to increased tariffs on pharmaceutical imports. (apnews.com) Conversely, the India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to eliminate or reduce tariffs on goods traded between India and EFTA countries, potentially opening new avenues for Scott Edil in European markets. (en.wikipedia.org)
Compliance with the European Union's Falsified Medicines Directive (FMD) is another critical factor. The directive mandates stringent serialization and traceability requirements to prevent counterfeit medicines. For Scott Edil, aligning with these regulations is essential to maintain and expand its presence in EU markets.
Scott Edil Pharmacia Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, particularly from agencies like the US FDA and the European Medicines Agency. For Indian exporters, maintaining compliance with Good Manufacturing Practices (GMP) is imperative. Scott Edil's WHO-GMP certification underscores its commitment to quality standards. (scott-edil.com) However, the industry faces challenges related to quality concerns and counterfeit drugs, which can impact reputations and market access. (fact.net.in) Continuous investment in quality assurance and regulatory compliance is crucial for Scott Edil to navigate these challenges effectively.
About Scott Edil Pharmacia Limited
Scott Edil Pharmacia Limited exports 23 products worth $25.5M. Beyond Lisinopril, top products include Ceftriaxone, Artesunate, Azithromycin, Ampicillin, Cephalexin. View the complete Scott Edil Pharmacia Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lisinopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lisinopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Scott Edil Pharmacia Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 21 individual customs records matching Scott Edil Pharmacia Limited exporting Lisinopril, covering 11 formulations to 4 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 450+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lisinopril Export Data from Scott Edil Pharmacia Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Scott Edil Pharmacia Limited's Lisinopril exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Scott Edil Pharmacia Limited
Full Company Profile →
23 products · $25.5M total trade · 10 categories
Lisinopril Stats
Company Overview
Top Products by Scott Edil Pharmacia Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Scott Edil Pharmacia Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lisinopril. For current shipment-level data, contact TransData Nexus.